Jinhua Qinggan granules, a traditional Chinese medicine that comprises 12 ingredients including honeysuckle, Baikal skullcap root and sweet wormwood herb, are effective in treating mild cases of COVID-19, according to a new study.
The paper posted Friday (May 20) on medRxiv, an online publisher of preliminary medical research findings, said a trial in August involving 300 volunteers at a Pakistani hospital showed it was effective in treating mild presentations of the disease.
The study’s participants, all adult with mild symptoms, were randomly assigned to receive either 5g of Jinhua Qinggan or placebo granules three times daily for 10 days. The participants were divided into two groups of 150. In total 256 patients completed the study, 129 taking Jinhua Qinggan and 127 the placebo.
Treatment using Jinhua Qinggan (JHQG) showed greater clinical efficacy at 82.67% after 10 days, compared with the placebo group at 10.74%, the researchers found.
The median time to recover from COVID-related symptoms including cough, sputum, sore throat, dyspnea, headache, nasal obstruction, fatigue, and myalgia was shorter in the JHQG group compared with the placebo group, the researchers said.